![]() |
|
searchpremium serviceseventsdirectory servicesadvertisingcustomer care |
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients Wockhardt Poised for U.S. Drug Launch1:20 PM MDT | July 31, 2007 | DR Wockhardt (Mumbai), a pharmaceuticals and biotechnology company, has received tentative approval from the U.S. FDA to market terbinafine tablets in the U.S. Terbinafine is the generic version of Novartis’s branded drug Lamisil. The U.S. product patent... This information is only available to Forgot your user ID or password?
|
Not an IHS Chemical Week
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|